(3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid

C23H25N5O9 — CID 91092855

IUPAC(3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid
SMILESO=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)C=Cc3ccc4c(c3)OCO4)C(=O)N12
InChIInChI=1S/C23H25N5O9/c29-12-15(11-21(32)33)24-22(34)16-2-1-8-27-20(31)7-9-26(23(35)28(16)27)25-19(30)6-4-14-3-5-17-18(10-14)37-13-36-17/h3-6,10,12,15-16H,1-2,7-9,11,13H2,(H,24,34)(H,25,30)(H,32,33)/t15-,16-/m0/s1
InChIKeyBPFQNWKQZPONQL-HOTGVXAUSA-N
MW515.48 g/mol
LogP-0.35
Rot. Bonds8

About (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid

(3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid (PubChem CID 91092855) has the molecular formula C23H25N5O9 and a molecular weight of 515.48 g/mol. Its IUPAC name is (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid.

Molecular Properties

Compound Name(3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid
PubChem CID91092855
Molecular FormulaC23H25N5O9
Molecular Weight515.48 g/mol
Exact Mass515.17
IUPAC Name(3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid
SMILESO=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)C=Cc3ccc4c(c3)OCO4)C(=O)N12
InChIInChI=1S/C23H25N5O9/c29-12-15(11-21(32)33)24-22(34)16-2-1-8-27-20(31)7-9-26(23(35)28(16)27)25-19(30)6-4-14-3-5-17-18(10-14)37-13-36-17/h3-6,10,12,15-16H,1-2,7-9,11,13H2,(H,24,34)(H,25,30)(H,32,33)/t15-,16-/m0/s1
InChIKeyBPFQNWKQZPONQL-HOTGVXAUSA-N
XLogP-0.35
TPSA174.89 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500515.48
LogP ≤ 5-0.35
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid?
The IUPAC name of (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid (CID 91092855) is (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid.
What is the SMILES notation for (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid?
The canonical SMILES for (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid is O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)C=Cc3ccc4c(c3)OCO4)C(=O)N12.
What is the InChIKey of (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid?
The InChIKey is BPFQNWKQZPONQL-HOTGVXAUSA-N. The full InChI is InChI=1S/C23H25N5O9/c29-12-15(11-21(32)33)24-22(34)16-2-1-8-27-20(31)7-9-26(23(35)28(16)27)25-19(30)6-4-14-3-5-17-18(10-14)37-13-36-17/h3-6,10,12,15-16H,1-2,7-9,11,13H2,(H,24,34)(H,25,30)(H,32,33)/t15-,16-/m0/s1.
What are the key properties of (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid?
(3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid has a molecular weight of 515.48 g/mol, XLogP of -0.35, 8 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-3-[[(10S)-2-[3-(1,3-benzodioxol-5-yl)prop-2-enoylamino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid is sourced from PubChem (CID 91092855), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).